Immix Biopharma Ownership | Who Owns Immix Biopharma?


OverviewFinancialsChart

Immix Biopharma Ownership Summary


Immix Biopharma is owned by 29.89% institutional investors, 22.37% insiders, and 47.74% retail investors. Vanguard group is the largest institutional shareholder, holding 3.43% of IMMX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.72% of its assets in Immix Biopharma shares.

IMMX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockImmix Biopharma29.89%22.37%47.74%
SectorHealthcare Stocks 232.51%10.72%-143.22%
IndustryBiotech Stocks 384.55%10.58%-295.13%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group1.10M3.43%$5.73M
Blue owl capital lp986.24K3.09%$5.16M
Franklin resources980.39K3.07%$5.13M
Bleichroeder lp850.00K2.83%$1.78M
Renaissance258.60K0.81%$1.35M
Geode capital management246.06K0.77%$1.29M
Goldman sachs group208.37K0.65%$1.09M
Jane street group167.13K0.52%$874.10K
Blackrock funding, inc. /de130.25K0.41%$681.23K
Morgan stanley126.62K0.40%$662.23K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Imprint wealth67.42K0.45%$140.91K
Blue owl capital lp986.24K0.39%$5.16M
Bleichroeder lp850.00K0.35%$1.78M
Eam investors120.86K0.07%$632.08K
Velan capital investment management lp35.00K0.07%$73.15K
Lgt fund management125.00K0.05%$660.00K
Mathes company10.65K0.02%$56.00K
Invst27.00K0.01%$57.24K
Tocqueville asset management68.55K0.01%$358.52K
Xtx topco35.15K0.00%$73.47K

Top Buyers

HolderShares% AssetsChange
Blue owl capital lp986.24K0.39%986.24K
Franklin resources980.39K0.00%980.39K
Vanguard group1.10M0.00%365.65K
Renaissance258.60K0.00%237.10K
Goldman sachs group208.37K0.00%208.37K

Top Sellers

HolderShares% AssetsChange
Aigh capital management---1.12M
Cable car capital---779.36K
Susquehanna group, llp---76.90K
Dimensional fund advisors lp---24.53K
Tritonpoint wealth---24.53K

New Positions

HolderShares% AssetsChangeValue
Blue owl capital lp986.24K0.39%986.24K$5.16M
Franklin resources980.39K0.00%980.39K$5.13M
Goldman sachs group208.37K0.00%208.37K$1.09M
Lgt fund management125.00K0.05%125.00K$660.00K
Eam investors120.86K0.07%120.86K$632.08K

Sold Out

HolderChange
Srs capital advisors-34.00
Tower research capital llc (trc)-131.00
Wells fargo & company/mn-330.00
Simplex trading-509.00
Raymond james financial-525.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202531-3.13%9,543,371243.79%2934.87%2728.57%433.33%
Sep 30, 20252618.18%1,748,673-18.18%511.48%1677.78%3-25.00%
Jun 30, 2025234.55%2,262,228-22.49%77.81%1042.86%4-50.00%
Mar 31, 20251-95.83%850,000-70.39%23.01%--100.00%--100.00%
Dec 31, 202412-55.56%1,006,179-75.43%31.77%4-50.00%4-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv488.61K1.72%-10.68K
Vanguard Institutional Extnd Mkt Idx Tr136.88K0.48%-62.37K
Fidelity Extended Market Index77.86K0.27%-641.00
Timber Point Global Allocations Instl40.00K0.14%-
iShares Micro-Cap ETF36.69K0.13%-
Fidelity Total Market Index22.16K0.08%-47.00
NT Ext Equity Mkt Idx Fd - L20.01K0.07%-
Northern Trust Extended Eq Market Idx20.01K0.07%-
Fidelity Series Total Market Index20.21K0.07%-
Spartan Extended Market Index Pool F19.70K0.07%641.00

Recent Insider Transactions


DateNameRoleActivityValue
Dec 10, 2025Rachman Ilya M CEO and ChairmanBuy$4.98K
Dec 10, 2025Morris Gabriel S CFOBuy$5.07K
Sep 17, 2025Rachman Ilya M CEO and ChairmanBuy$5.05K
Sep 16, 2025Morris Gabriel S CFOBuy$5.12K
Jun 18, 2025Rachman Ilya M CEO and ChairmanBuy$5.00K

Insider Transactions Trends


DateBuySell
2025 Q42-
2025 Q32-
2025 Q22-
2024 Q42-
2024 Q35-

IMMX Ownership FAQ


Who Owns Immix Biopharma?

Immix Biopharma shareholders are primarily institutional investors at 29.89%, followed by 22.37% insiders and 47.74% retail investors. The average institutional ownership in Immix Biopharma's industry, Biotech Stocks , is 384.55%, which Immix Biopharma falls below.

Who owns the most shares of Immix Biopharma?

Immix Biopharma’s largest shareholders are Vanguard group (1.1M shares, 3.43%), Blue owl capital lp (986.24K shares, 3.09%), and Franklin resources (980.39K shares, 3.07%). Together, they hold 9.59% of Immix Biopharma’s total shares outstanding.

Does Blackrock own Immix Biopharma?

BlackRock is not among the top 10 institutional shareholders of Immix Biopharma.

Who is Immix Biopharma’s biggest shareholder by percentage of total assets invested?

Imprint wealth is Immix Biopharma’s biggest shareholder by percentage of total assets invested, with 0.45% of its assets in 67.42K Immix Biopharma shares, valued at 140.91K$.

Who is the top mutual fund holder of Immix Biopharma shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Immix Biopharma shares, with 1.72% of its total shares outstanding invested in 488.61K Immix Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools